End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
7.72
CNY
|
-0.77%
|
|
-3.02%
|
-4.57%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,484
|
5,100
|
4,254
|
7,164
|
9,180
|
5,754
|
Enterprise Value (EV)
1 |
2,476
|
5,452
|
4,585
|
7,261
|
9,219
|
5,992
|
P/E ratio
|
39.8
x
|
55.9
x
|
104
x
|
105
x
|
29.2
x
|
49.6
x
|
Yield
|
-
|
0.35%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.26
x
|
4.05
x
|
2.8
x
|
3.81
x
|
3.83
x
|
3.08
x
|
EV / Revenue
|
4.24
x
|
4.33
x
|
3.02
x
|
3.86
x
|
3.84
x
|
3.2
x
|
EV / EBITDA
|
32.2
x
|
30.7
x
|
23.3
x
|
24.8
x
|
13.1
x
|
15.5
x
|
EV / FCF
|
-25.8
x
|
-27.7
x
|
143
x
|
-22.5
x
|
96.8
x
|
-30.1
x
|
FCF Yield
|
-3.87%
|
-3.61%
|
0.7%
|
-4.44%
|
1.03%
|
-3.32%
|
Price to Book
|
4.11
x
|
7.33
x
|
5.64
x
|
5.61
x
|
5.71
x
|
2.98
x
|
Nbr of stocks (in thousands)
|
592,801
|
592,801
|
592,801
|
681,816
|
681,908
|
711,217
|
Reference price
2 |
4.190
|
8.603
|
7.177
|
10.51
|
13.46
|
8.090
|
Announcement Date
|
2/27/19
|
4/26/20
|
4/27/21
|
4/26/22
|
3/27/23
|
4/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
583.7
|
1,260
|
1,517
|
1,881
|
2,399
|
1,871
|
EBITDA
1 |
76.93
|
177.3
|
196.6
|
292.8
|
701.9
|
385.5
|
EBIT
1 |
64.45
|
99.88
|
90.73
|
168.8
|
569.1
|
224
|
Operating Margin
|
11.04%
|
7.93%
|
5.98%
|
8.98%
|
23.73%
|
11.97%
|
Earnings before Tax (EBT)
1 |
70.56
|
107
|
36.96
|
116
|
562.5
|
180.2
|
Net income
1 |
63.3
|
90.11
|
41.92
|
63.28
|
317.1
|
115
|
Net margin
|
10.84%
|
7.15%
|
2.76%
|
3.36%
|
13.22%
|
6.14%
|
EPS
2 |
0.1053
|
0.1538
|
0.0692
|
0.1000
|
0.4615
|
0.1632
|
Free Cash Flow
1 |
-95.86
|
-196.7
|
32.05
|
-322
|
95.22
|
-199.1
|
FCF margin
|
-16.42%
|
-15.61%
|
2.11%
|
-17.12%
|
3.97%
|
-10.64%
|
FCF Conversion (EBITDA)
|
-
|
-
|
16.3%
|
-
|
13.57%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
76.46%
|
-
|
30.03%
|
-
|
Dividend per Share
|
-
|
0.0304
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/19
|
4/26/20
|
4/27/21
|
4/26/22
|
3/27/23
|
4/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
352
|
330
|
96.5
|
39.7
|
238
|
Net Cash position
1 |
8.33
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.988
x
|
1.68
x
|
0.3296
x
|
0.0566
x
|
0.6174
x
|
Free Cash Flow
1 |
-95.9
|
-197
|
32
|
-322
|
95.2
|
-199
|
ROE (net income / shareholders' equity)
|
10.6%
|
13.4%
|
3.33%
|
8.38%
|
28.7%
|
7.72%
|
ROA (Net income/ Total Assets)
|
4.53%
|
4.53%
|
3.03%
|
4.73%
|
12.8%
|
4.35%
|
Assets
1 |
1,397
|
1,987
|
1,384
|
1,338
|
2,468
|
2,643
|
Book Value Per Share
2 |
1.020
|
1.170
|
1.270
|
1.870
|
2.360
|
2.720
|
Cash Flow per Share
2 |
0.2800
|
0.4000
|
0.3300
|
0.4800
|
0.6500
|
0.5500
|
Capex
1 |
142
|
295
|
108
|
327
|
378
|
526
|
Capex / Sales
|
24.24%
|
23.41%
|
7.11%
|
17.38%
|
15.75%
|
28.09%
|
Announcement Date
|
2/27/19
|
4/26/20
|
4/27/21
|
4/26/22
|
3/27/23
|
4/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -4.57% | 760M | | +17.80% | 66.73B | | +2.92% | 49.79B | | +19.98% | 42.5B | | +20.88% | 26.45B | | +12.04% | 19.66B | | +1.27% | 17.18B | | -22.98% | 15.82B | | +2.77% | 15.56B | | -9.25% | 15.41B |
Other Specialty Chemicals
|